A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors
Clinical trial NCT05508659 · UNKNOWN
Trial details
- NCT number
- NCT05508659
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2024-09-20
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.